Obermeyer Wealth Partners’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-90,134
Closed -$14.7M 126
2017
Q4
$14.7M Sell
90,134
-72,939
-45% -$13.1M 1.28% 26
2017
Q3
$33.4M Sell
163,073
-185
-0.1% -$43K 2.9% 13
2017
Q2
$39.7M Buy
163,258
+24
+0% +$5.64K 3.52% 8
2017
Q1
$39M Buy
163,234
+5,759
+4% +$1.34M 3.59% 10
2016
Q4
$33.1M Sell
157,475
-18,609
-11% -$3.85M 3.16% 12
2016
Q3
$40.6M Sell
176,084
-4,651
-3% -$1.14M 3.89% 7
2016
Q2
$41.8M Sell
180,735
-3,600
-2% -$830K 4.16% 6
2016
Q1
$49.4M Buy
184,335
+1,531
+0.8% +$438K 4.58% 6
2015
Q4
$57.1M Buy
+182,804
New +$54.4M 5.21% 2

Other funds holding AGN

Obermeyer Wealth Partners's AGN Position: Q1 2018 in Review

Obermeyer Wealth Partners sold out of Allergan plc (AGN) in Q1 2018, closing a stake of 90,134 shares — an estimated $14.7M sold.

Obermeyer Wealth Partners first reported a position in AGN in Q4 2015 and held it in 9 quarters. The position peaked at $57.1M in Q4 2015. 1,022 funds tracked by Wall St. Rank hold AGN as of Q1 2018.

  • Obermeyer Wealth Partners reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
  • Obermeyer Wealth Partners sold 90,134 Allergan plc shares in Q1 2018, an estimated $14.7M.
  • Obermeyer Wealth Partners first reported a position in Allergan plc in Q4 2015 and held it in 9 quarters.
  • Obermeyer Wealth Partners's Allergan plc position peaked at $57.1M in Q4 2015.
  • 1,022 funds tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on Obermeyer Wealth Partners's 13F filing for Q1 2018, filed 7 May 2018.